PHGE
USDBiomX Inc. COmmon Stock
$0.396-0.004 (-1.050%)
Real-time Price
Healthcare
Biotechnology
Israel
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.400
High
$0.405
Low
$0.387
Volume
53.15M
Company Fundamentals
Market Cap
10.4M
Industry
Biotechnology
Country
Israel
Trading Stats
Avg Volume
1.09M
Exchange
ASE
Currency
USD
52-Week Range
Low $0.34Current $0.396High $3.2
Related News
GlobeNewswire
BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis
First patient dosing in Company's Phase 2b trial marks pivotal milestone in phage therapy development program targeting antibiotic-resistant lung infections in Cystic Fibrosis patients; topline results are expected in Q1
View more
Related Stocks
FLNG
FLEX LNG Ltd. Ordinary Shares
NASDAQ
Marine Transpor...
AIU
Meta Data Limited American Depositary Shares each representing ten (10) Ordinary Shares
NASDAQ
Other Consumer ...
ZOM
Zomedica Corp. Common Shares
NASDAQ
Pharmaceuticals...
ENZ
Enzo Biochem Inc. ($0.01 Par Value)
NASDAQ
Medical Special...
HIG
Hartford (The)
SP500
Property & Casu...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.